CH699182A1 - bee honey mixtures for dermatological treatment of chronic wounds. - Google Patents

bee honey mixtures for dermatological treatment of chronic wounds. Download PDF

Info

Publication number
CH699182A1
CH699182A1 CH01114/08A CH11142008A CH699182A1 CH 699182 A1 CH699182 A1 CH 699182A1 CH 01114/08 A CH01114/08 A CH 01114/08A CH 11142008 A CH11142008 A CH 11142008A CH 699182 A1 CH699182 A1 CH 699182A1
Authority
CH
Switzerland
Prior art keywords
honey
mixture
dermatological treatment
chronic wounds
mix
Prior art date
Application number
CH01114/08A
Other languages
French (fr)
Other versions
CH699182B1 (en
Inventor
Sasi Dharan
Guenter Holzner
Original Assignee
Care Cosmeceuticals Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Care Cosmeceuticals Sarl filed Critical Care Cosmeceuticals Sarl
Priority to CH01114/08A priority Critical patent/CH699182B1/en
Publication of CH699182A1 publication Critical patent/CH699182A1/en
Publication of CH699182B1 publication Critical patent/CH699182B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A61K8/988Honey; Royal jelly, Propolis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624Nanocapsules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mixture of honey of honeybees comprises mixture of microbicides and antiinflammatory products and epithelizing agents of which their composition is adapted to the biochemical medium during different stages of healing. ACTIVITY : Vulnerary. MECHANISM OF ACTION : None given.

Description

       

  Introduction:

  

[0001]    La guérison des plaies suit normalement quatre étapes: Homéostasies - Inflammation - Prolifération - Remodelisation [Douglas MacKay and Alan Miller, Nutritional Support for Wound Healing, Alternative Medicine Review, Vol. 8, No 4, 2003]. Pour nos considérations phase 2 et 3 sont les plus importants.

  

[0002]    Phase de l'inflammation (phase destructive) qui provoque par des enzymes spécifiques une lyse des cellules blessées. Des essais ont montré qu'il s'agit au point de vue biochimique des réactions d'oxydation initiées par des radicaux libres et des peroxydes [P. Dubouloz, Sur la formation de peroxydes lipidiques dans la peau après action de divers agents physiques, thèse 097 896, 1954, fac. Des Sciences Univ. de Marseille].

  

[0003]    Phase d'épithelisation (phase proliférative) caractérisée par. la formation du nouveau tissu pour fermer la plaie. Cette phase requiert de préférence un milieu réducteur biochimiquement parlant.

  

[0004]    Certaines maladies, surtout le diabète, perturbent l'équilibre Redox de la guérison. Les plaies restent dans la première phase d'inflammation oxydative et ne guérissent pas. Les cellules ne sont pas aptes de changer de la phase inflammatoire oxydative à la phase d'épitelisation réductive. En plus l'inflammation prolongée expose la plaie aux infections par des mieroorganismes [voir aussi: Jorge de la Torre, The Physiology of Healing of the Chrome Wound, medicine from WebMD, May 26, 2006].

Description de la technique actuelle

  

[0005]    Aujourd'hui le problème de ces plaies chroniques n'est pas encore résolu à la satisfaction des patients.

  

[0006]    Des crèmes et poudres ayant une action bactéricide empêchent une infection des plaies mais ne les peuvent pas guérir complètement.

  

[0007]    Un des remèdes les plus vieux pour accélérer la guérison des plaies superficielles est le miel. Des mélanges du miel avec l'huile de foie de morue et avant depuis l'antiquité avec des résines végétales ont été utilisés et testés récemment [ M. Lofty et al., Combined use of honey, bee propolis and myrrh in healing a deep, infeeted wound in a patient with diabètes mellitus, Brit. Journ. of Biomed. Science, 2006, 63 (4), pages 171-173]. L'activité du miel est relativement restreinte et de ce fait son utilisation a été supplantée par des remèdes plus modernes. Son action est surtout bactéricide et dépend fortement de son origine.

   Le miel du tea tree (Manuka - honey) de la Nouvelle Zealande a-montré une activité plus prononcée que d'autres sortes [Shna Abdurahman, M vitro interaction between methcillin-resistant S.aureus and varions types of honey, The Biomédical Scientist, Nov. 2007 Pages 908-909].

  

[0008]    Les acides aminés cysteine, glycine et threonine ont été essayé pour la guérison des plaies [S.G. Harvey and J.R. Gibson, The effects on wound healing of three amino acids - a comparison of two models, Brit. Journ. of Dermat. Vol.lll, Issue s27, page 171, July 1984].

  

[0009]    Un brevet canadien concerne une large gamme des acides aminés pour la guérison des plaies [Can. Pat. No-2 455 776: Composition à base d'acides aminés appropriées en thérapie pour guérir et/ou panser des plaies et des lésions, notamment utilisées dans le domaine de l'ophtalmologie].

Description de l'invention

  

[0010]    Les conclusions théoriques concernant le déséquilibre du système Redox dans des plaies chroniques et mal guérissables nous ont mené vers une combinaison des produits qui sont adaptés aux conditions biologiques et biochimiques de la plaie du début de F inflammation jusqu'à guérison complète. Ces préparations pour traiter la plaie chronique ont d'abord une action à prédominance microbicide' et doivent faciliter le nettoyage de la plaie pour contrôler une infection. Ensuite la composition du mélange traitante va aider au tissu de la plaie de quitter la phase inflammatoire (oxydative) et mduire un milieu antioxydant et réducteur qui est favorable a l'épithelisation et finalement à la guérison complète.

  

[0011]    Depuis l'antiquité le miel des abeilles est utilisé pour le traitement des plaies. Son action connue est surtout bactériostatique. Quelques sortes ont même une action légèrement bactéricide.

  

[0012]    Après l'analyse de beaucoup de sortes de miel nous avons trouvé que le miel en provenance de Lavandula stoechas L. (Rosmaninho) au Portugal montre une action bactéricide presque aussi prononcée que le miel de Manuka et nettement plus forte que d'autres sortes trouvées en Europe.

  

[0013]    A part de cette action bactéricide relativement faible le miel a une action réductrice grâce à sa teneur en monosaccharides (34-41% fructose, 28-35% glucose). Ceci le rend idéal comme base d'application pour des produits sensibles à l'oxydation comme les antioxydants et les vitamines et certains extraits de plantes.

  

[0014]    Les résultats de guérison de ces mélanges nouveaux sont tout à fait extraordinaires et pas connus dans le milieu médical. De ce fait les mélanges décrits en détail par la suite font l'objet de cette demande de brevet.

Exemples de mélanges du miel avec d'autres substances actives pour traiter les plaies chroniques.

Exemple 1: augmentation de l'activité bactéricide du miel avec le nanosilver

  

[0015]    
<tb>Miel<sep>99,0 %


  <tb>Sanitized BC A 21-41*<sep>1,0


  <tb><sep>100,0

  

[0016]    *Des ions d'argent encapsulés dans une matrice en verre, contient 15% d'argent. Fabricant: Clariant AG, Basel

  

[0017]    Ce mélange peut être appliqué à l'aide d'une spatule sur la plaie, mais peut aussi servir à imbiber des pansements.

Exemple 2: solution miel avec Aloe et nanosilver en suspension

  

[0018]    
<tb>Miel<sep>50,0 %


  <tb>Jus d'aloe barbadensis frais, non traité<sep>48,5


  <tb>Sanitized BC A 21-41<sep>1,5


  <tb>Conservateur<sep>q.s.

  

[0019]    Ce mélange est assez liquide. Pour faciliter l'utilisation sur des plaies on peut faire les applications suivantes:
<tb>a) Spray:<sep>la solution est remplie dans un flacon avec pompe vaporisateur.


  <tb>b) Gel:<sep>par adjonction d'un gélifiant la viscosité est fortement augmentée. Le gel résultant est appliqué par une spatule.

Exemple 3: combinaison du miel avec des antioxydants

  

[0020]    Le miel avec son milieu réducteur est idéal pour garder en solution ou suspension des produits sensibles contre l'oxydation. Ceci est le cas avec la plupart des antioxydants et vitamines. Nos essais ont montré que la combinaison du miel avec des antioxydants et des vitamines amène une meilleure guérison et cicatrisation des plaies.

  

[0021]    Les antioxydants sont des substances qui protègent des biomolécules, surtout les acides polyunsaturés des membranes cellulaires et finalement les cellules eux mêmes contre la destruction par l'oxydation. Cette protection est effectuée par l'inactivation des radicaux libres, des peroxydes et des traces de métaux catalytiques (Fer, Cuivre). Détails voir brevet suisse Gunter Holzner CH 695 414 A5, 30.05.2001).

Formule d'application:

  

[0022]    
<tb>Miel<sep>90,0%


  <tb>Tocophérol (Coviox -70 de Cognis,Diisseldorf)<sep>10,0


  <tb><sep>100,0

Exemple 4: combinaison du miel avec antioxydants, vitamines et acides aminés:

  

[0023]    
<tb>Super miel 1<sep>


  <tb>Vitamine E<sep>2,0%


  <tb>Miel<sep>89,4


  <tb>Essence Girofle<sep>1,6


  <tb>Vitamine C<sep>3,0


  <tb>Taurine<sep>1,0


  <tb>Acides aminés SD<sep>2,0


  <tb>Vitamines SD<sep>1,0


  <tb><sep>100,0
<tb>Super miel 2<sep>


  <tb>Vitamine E<sep>2,5%


  <tb>Miel<sep>86,0


  <tb>Sanitized BC A 21-41*<sep>0,7


  <tb>Essence Girofle<sep>1,6


  <tb>Vitamine C<sep>3,0


  <tb>Taurine<sep>1,0


  <tb>Acides aminés SD<sep>2,0


  <tb>Vitamines SD<sep>1,0


  <tb>Vitamine D3 1 mio Unités<sep>0,2


  <tb>Correspond à 50mg/kg<sep>


  <tb>Lécithine tournesol<sep>2,0


  <tb><sep>100,0

Exemple 5: Miel gélifié

  

[0024]    Des gélifiants donnant des bons résultats sont les polyacrylates par exemple Cosmedia SP (Na-polyacrylate de Cognis AG, Düsseldorf) ou Aristoflex AVC et Aristoflex HMB (Ammonium-Acryloyldimethyltaurate/VP copolymère de Clariant AG, Basel). Autres gélifiants pourraient être les dérives cellulosiques, les Xanthanes et les dérives du Guar. Comme gélifiants anorganiques on peut utiliser des Montmorillonites (silicates en couches qui gonflent avec de l'eau). Dans la plupart des cas 2-5% gélifiant sont suffisants pour obtenir un gel stable et d'une consistance correcte.
<tb>Gel Miel 2<sep>


  <tb>Part A<sep>


  <tb>Alcool éthylique 94%<sep>20,0%


  <tb>Eau<sep>31,8


  <tb>Taurin<sep>1,0


  <tb>Aloe 200x extrait lyophilisé<sep>0,5


  <tb>Miel<sep>30,0


  <tb><sep>


  <tb>PartB<sep>


  <tb>Propylheptyl Caprylate<sep>12,0


  <tb>Dilaurylthiodipropionate<sep>0,5


  <tb>Vitamine E<sep>2,0


  <tb>Aristoflex AVC<sep>1,5


  <tb>Aristoflex HMB<sep>0,7


  <tb><sep>100,0

Example 6: miel gélifié avec nanosilver

  

[0025]    
<tb>Gel Miel 3<sep>


  <tb>Part A<sep>


  <tb>Alcool 94%<sep>20,0%


  <tb>Eau<sep>26,0


  <tb>Taurin<sep>1,0


  <tb>Aloe 200x<sep>0,5


  <tb>Miel<sep>30,0


  <tb>Vitamines SD (1)<sep>1,0


  <tb>Acides aminés SD (2)<sep>2,0


  <tb><sep>


  <tb>Part B<sep>


  <tb>Propylheptyl Caprylate<sep>12,0


  <tb>Dilaurylthiodipropionate<sep>0,5


  <tb>Sanitized BC A 21-41*<sep>0,6


  <tb>Vitamine E<sep>2,0


  <tb>Aristoflex AVC<sep>1,5


  <tb>Aristoflex HMB<sep>0,7


  <tb>Lécithine<sep>2,0


  <tb>Vitamine D3<sep>0,2


  <tb><sep>100,0

  

[0026]    Fabrication: mélanger séparément Part A et B. Après mélanger les deux parts et bien homogénéiser.

  

[0027]    Les préparations de l'exemple 5 et 6 contiennent moins de miel mais d'avantage des produits cicatrisants et épithelisants. Elles sont destinées pour le traitement de la deuxième phase jusqu à la guérison complète.

(1) Composition des acides aminés SD:

  

[0028]    
<tb><sep>g pro litre solution


  <tb>L-Arginine<sep>10,0


  <tb>L-Asparagine. H20<sep>2,8


  <tb>L-Cystine<sep>2,5


  <tb>L-Isoleucine<sep>2,5


  <tb>L- Leucine<sep>2,5


  <tb>L-Lysine.HCl<sep>2,0


  <tb>L-Serine<sep>1,5


  <tb>L- Tyrosine<sep>1,2


  <tb>L- Proline<sep>1,0


  <tb>L-Valine<sep>1,0

(2) Composition des vitamines SD:

  

[0029]    
<tb><sep>g pro litre solution


  <tb>Myo-Inositol<sep>3,5


  <tb>Chlorure de Choline<sep>0,3


  <tb>Acide Folique<sep>0,1


  <tb>Niacinamide<sep>0,1


  <tb>Pyridoxine HC1<sep>0,1


  <tb>Thiamine HC1<sep>0,1



  Introduction:

  

[0001] Wound healing normally follows four stages: Homeostasis - Inflammation - Proliferation - Remodeling [Douglas MacKay and Alan Miller, Nutritional Support for Wound Healing, Alternative Medicine Review, Vol. 8, No. 4, 2003]. For our considerations phase 2 and 3 are the most important.

  

Phase of inflammation (destructive phase) which causes specific enzymes lysis of injured cells. Tests have shown that it is a biochemical point of view of the oxidation reactions initiated by free radicals and peroxides [P. Dubouloz, On the formation of lipid peroxides in the skin after action of various physical agents, Thesis 097 896, 1954, fac. Science Univ. from Marseille].

  

[0003] Epithelization phase (proliferative phase) characterized by. the formation of new tissue to close the wound. This phase preferably requires a reducing medium biochemically speaking.

  

[0004] Certain diseases, especially diabetes, disrupt the redox balance of healing. The wounds remain in the first phase of oxidative inflammation and do not heal. The cells are not able to change from the oxidative inflammatory phase to the reductive epitelization phase. In addition the prolonged inflammation exposes the wound to infections by superorganisms [see also: Jorge de la Torre, The Physiology of Healing of the Chrome Wound, Medicine from WebMD, May 26, 2006].

Description of the current technique

  

[0005] Today the problem of these chronic wounds is not yet solved to the satisfaction of the patients.

  

Creams and powders having a bactericidal action prevent infection of wounds but can not heal them completely.

  

[0007] One of the oldest remedies for accelerating the healing of superficial wounds is honey. Mixtures of honey with cod liver oil and since ancient times with plant resins have been used and tested recently [Lofty et al., Combined use of honey, bee propolis and myrrh in healing a deep, infeeted wound in a patient with diabetes mellitus, Brit. Journ. of Biomed. Science, 2006, 63 (4), pages 171-173]. The activity of honey is relatively limited and therefore its use has been supplanted by more modern remedies. Its action is mostly bactericidal and strongly dependent on its origin.

   Tea tree honey (Manuka - honey) from New Zealand has shown more activity than other types [Shna Abdurahman, M vitro interaction between methcillin - resistant S.aureus and varions types of honey, The Biomedical Scientist, Nov. 2007 Pages 908-909].

  

The amino acids cysteine, glycine and threonine have been tried for healing wounds [S.G. Harvey and J. R. Gibson, The effects on wound healing of three amino acids - a comparison of two models, Brit. Journ. of Dermat. Vol.lll, Issue s27, page 171, July 1984].

  

[0009] A Canadian patent relates to a wide range of amino acids for healing wounds [Can. Pat. No. 2,455,776: Amino Acid-Based Composition Suitable for Therapy in Curing and / or Dressing Wounds and Lesions, Particularly Used in the Field of Ophthalmology].

Description of the invention

  

Theoretical conclusions concerning the imbalance of the Redox system in chronic wounds and poorly curable led us to a combination of products that are adapted to the biological and biochemical conditions of the wound from the beginning of inflammation until complete healing. These preparations for treating the chronic wound first have a predominantly microbicidal action and should facilitate the cleaning of the wound to control an infection. Thereafter, the composition of the treating mixture will help the wound tissue to leave the inflammatory (oxidative) phase and provide an antioxidant and reducing medium that is favorable for epithelization and ultimately for complete healing.

  

Since ancient times honey bees is used for the treatment of wounds. Its known action is mainly bacteriostatic. Some kinds even have a slightly bactericidal action.

  

After analyzing many kinds of honey we found that the honey from Lavandula stoechas L. (Rosmaninho) in Portugal shows a bactericidal action almost as pronounced as the Manuka honey and significantly stronger than other kinds found in Europe.

  

Apart from this relatively low bactericidal action honey has a reducing action due to its content of monosaccharides (34-41% fructose, 28-35% glucose). This makes it ideal as an application base for oxidation-sensitive products such as antioxidants and vitamins and some plant extracts.

  

The healing results of these new mixtures are quite extraordinary and not known in the medical community. As a result, the mixtures described in detail below are the subject of this patent application.

Examples of mixtures of honey with other active substances to treat chronic wounds.

Example 1: Increasing the Bactericidal Activity of Honey with the Nanosilver

  

[0015]
<tb> Honey <sep> 99.0%


  <tb> Sanitized BC A 21-41 * <sep> 1.0


  <Tb> <September> 100.0

  

* Silver ions encapsulated in a glass matrix, contains 15% silver. Manufacturer: Clariant AG, Basel

  

This mixture can be applied with a spatula on the wound, but can also be used to soak dressings.

Example 2: honey solution with Aloe and nanosilver in suspension

  

[0018]
<tb> Honey <sep> 50.0%


  <tb> fresh aloe barbadensis juice, untreated <sep> 48.5


  <tb> Sanitized BC A 21-41 <sep> 1.5


  <Tb> Conservative <September> q.s..

  

This mixture is quite liquid. To facilitate the use on wounds one can make the following applications:
<tb> a) Spray: <sep> the solution is filled into a vial with a spray pump.


  <tb> b) Gel: <sep> by adding a gelling agent the viscosity is greatly increased. The resulting gel is applied by a spatula.

Example 3: Combination of honey with antioxidants

  

Honey with its reducing medium is ideal for keeping in solution or suspension of sensitive products against oxidation. This is the case with most antioxidants and vitamins. Our trials have shown that the combination of honey with antioxidants and vitamins leads to better healing and healing of wounds.

  

Antioxidants are substances that protect biomolecules, especially the polyunsaturated acids of cell membranes and finally the cells themselves against destruction by oxidation. This protection is carried out by the inactivation of free radicals, peroxides and traces of catalytic metals (iron, copper). Details see Swiss patent Gunter Holzner CH 695 414 A5, 30.05.2001).

Application formula:

  

[0022]
<Tb> Honey <September> 90.0%


  <tb> Tocopherol (Coviox-70 from Cognis, Diisseldorf) <sep> 10.0


  <Tb> <September> 100.0

Example 4: Combination of honey with antioxidants, vitamins and amino acids:

  

[0023]
<tb> Super honey 1 <sep>


  <tb> Vitamin E <sep> 2.0%


  <Tb> Honey <September> 89.4


  <tb> Clove oil <sep> 1,6


  <tb> Vitamin C <sep> 3.0


  <Tb> Taurine <September> 1.0


  <tb> SD <sep> 2.0 amino acids


  <tb> Vitamins SD <sep> 1.0


  <Tb> <September> 100.0
<tb> Super honey 2 <sep>


  <tb> Vitamin E <sep> 2.5%


  <Tb> Honey <September> 86.0


  <tb> Sanitized BC A 21-41 * <sep> 0.7


  <tb> Clove oil <sep> 1,6


  <tb> Vitamin C <sep> 3.0


  <Tb> Taurine <September> 1.0


  <tb> SD <sep> 2.0 amino acids


  <tb> Vitamins SD <sep> 1.0


  <tb> Vitamin D3 1 mio Units <sep> 0.2


  <tb> Corresponds to 50mg / kg <sep>


  <tb> Lecithin sunflower <sep> 2,0


  <Tb> <September> 100.0

Example 5: Gelled Honey

  

Gelling agents giving good results are polyacrylates, for example Cosmedia SP (Na-polyacrylate from Cognis AG, Düsseldorf) or Aristoflex AVC and Aristoflex HMB (Ammonium-Acryloyldimethyltaurate / VP copolymer from Clariant AG, Basel). Other gelling agents could be cellulosic drifts, Xanthans and Guar drifts. As inorganic gelling agents can be used Montmorillonites (layered silicates that swell with water). In most cases 2-5% gelling agent is sufficient to obtain a stable gel and of a correct consistency.
<tb> Honey Gel 2 <sep>


  <tb> Part A <sep>


  <tb> Ethyl alcohol 94% <sep> 20.0%


  <Tb> Water <September> 31.8


  <Tb> Taurin <September> 1.0


  <tb> Aloe 200x freeze-dried extract <sep> 0.5


  <Tb> Honey <September> 30.0


  <Tb> <September>


  <Tb> PartB <September>


  <tb> Propylheptyl Caprylate <sep> 12.0


  <Tb> dilauryl <September> 0.5


  <tb> Vitamin E <sep> 2.0


  <tb> Aristoflex AVC <sep> 1.5


  <tb> Aristoflex HMB <sep> 0.7


  <Tb> <September> 100.0

Example 6: Gel honey with nanosilver

  

[0025]
<tb> Honey Gel 3 <sep>


  <tb> Part A <sep>


  <tb> Alcohol 94% <sep> 20.0%


  <Tb> Water <September> 26.0


  <Tb> Taurin <September> 1.0


  <tb> Aloe 200x <sep> 0.5


  <Tb> Honey <September> 30.0


  <tb> Vitamins SD (1) <sep> 1.0


  <tb> Amino acids SD (2) <sep> 2,0


  <Tb> <September>


  <tb> Part B <sep>


  <tb> Propylheptyl Caprylate <sep> 12.0


  <Tb> dilauryl <September> 0.5


  <tb> Sanitized BC A 21-41 * <sep> 0.6


  <tb> Vitamin E <sep> 2.0


  <tb> Aristoflex AVC <sep> 1.5


  <tb> Aristoflex HMB <sep> 0.7


  <Tb> Lecithin <September> 2.0


  <tb> Vitamin D3 <sep> 0.2


  <Tb> <September> 100.0

  

Manufacturing: separately mix Part A and B. After mixing the two parts and homogenize well.

  

The preparations of Example 5 and 6 contain less honey but more healing and epithelizing products. They are intended for the treatment of the second phase until complete healing.

(1) Composition of amino acids SD:

  

[0028]
<tb> <sep> g pro liter solution


  <Tb> L-Arginine <September> 10.0


  <Tb> L-asparagine. H20 <September> 2.8


  <Tb> L-Cystine <September> 2.5


  <Tb> L-Isoleucine <September> 2.5


  <tb> L-Leucine <sep> 2.5


  <Tb> L-Lysine.HCl <September> 2.0


  <Tb> L-Serine <September> 1.5


  <tb> L-Tyrosine <sep> 1,2


  <tb> L-Proline <sep> 1.0


  <Tb> L-Valine <September> 1.0

(2) Composition of the vitamins SD:

  

[0029]
<tb> <sep> g pro liter solution


  <Tb> Myo-Inositol <September> 3.5


  <tb> Choline Chloride <sep> 0.3


  <tb> Folic acid <sep> 0,1


  <Tb> Niacinamide <September> 0.1


  <tb> Pyridoxine HC1 <sep> 0.1


  <tb> Thiamine HC1 <sep> 0.1


    

Claims (12)

1. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques caractérisé par le fait que le miel contient seul ou en mélange des produits microbicides et anti-inflammatoires et épithelisants dont leur composition est adaptée au milieu biochimique lors de différents stades de la guérison. 1. Mix of honey bees for the dermatological treatment of chronic wounds characterized in that the honey contains alone or in mixture microbicides and anti-inflammatory and epithelizing products whose composition is adapted to the biochemical environment during different stages of the healing. 2. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, caractérisé par le fait que le miel contient 0,1 - 5,0%, de préférence 0,5 - 1,0% d'un composé argenté sous forme des particules fines de l'argent colloïdal, d'un sel d'argent bactéricide ou des particules couverts d'une couche d'argent. 2. Mix of honey bees for the dermatological treatment of chronic wounds according to claim 1, characterized in that the honey contains 0.1 - 5.0%, preferably 0.5 - 1.0% of a compound silver in the form of fine particles of colloidal silver, a bactericidal silver salt or particles covered with a layer of silver. 3. Mélange de miel d'abeilles pour le traitement dermatologique des plaies difficilement chroniques selon revendication 1 et 2, caractérisé par le fait que le mélange contient en plus des antioxydants qui inactivent des radicaux libres et des peroxydes, de préférence de l'acide ascorbique et ses dérives stables, les vitamines A, B, D et E, tannin et ses dérivés lipophiles, carotène, astaxanthine, BHT (p-hydroxytoluene), BHA (p-hydroxyanisole), des polyphenols extrait des plantes (romarin, feuilles d'olivier, thé vert), DLTDP (dilaurylthiodipropionate), DTT (dithiothreitol), MSM (methylsulfonylmethane), Mélatonine, de l'acide thioglycolique et l'acide thioctique (acide 1,2 dithiolan-3 pentanoique) et des enzymes antioxydants ( SOD, GPO). 3. Mix of honey bees for the dermatological treatment of wounds with chronic difficulty according to claims 1 and 2, characterized in that the mixture additionally contains antioxidants which inactivate free radicals and peroxides, preferably ascorbic acid and its stable drifts, vitamins A, B, D and E, tannin and its lipophilic derivatives, carotene, astaxanthin, BHT (p-hydroxytoluene), BHA (p-hydroxyanisole), polyphenols extracted from plants (rosemary, leaves). olive, green tea), DLTDP (dilaurylthiodipropionate), DTT (dithiothreitol), MSM (methylsulfonylmethane), melatonin, thioglycolic acid and thioctic acid (3-dithiolan-3-pentanoic acid) and antioxidant enzymes (SOD, GPO). 4. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2 et 3, caractérisé par le fait que ce mélange contient des donateurs des groupes "méthyle", de préférence du betaine, choline, acetylcholine, lécithine, carnitine et taurine. 4. Mix of honey bees for the dermatological treatment of chronic wounds according to claims 1, 2 and 3, characterized in that this mixture contains donors of "methyl" groups, preferably betaine, choline, acetylcholine, lecithin, carnitine and taurine. 5. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3 et 4, caractérisé par le fait que ce mélange contient une combinaison des acides aminés, des vitamines et des sels minéraux qui favorise la croissance des tissues cellulaires. 5. Mix of honey bees for the dermatological treatment of chronic wounds according to claim 1, 2, 3 and 4, characterized in that this mixture contains a combination of amino acids, vitamins and mineral salts which promotes the growth of cellular tissues. 6. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4 et 5, caractérisé par le fait que ce mélange contient des extraits de plantes, de préférence le jus d'aloe et des polymères biologiques, de préférence de l'acide hyaluronique ou de ses sels et des huiles essentielles ayant un effet bactéricide et lénitive, de préférence de l'essence de girofle, lavande, cèdre et vétiver. 6. honey bee mixture for the dermatological treatment of chronic wounds according to claim 1, 2, 3, 4 and 5, characterized in that this mixture contains plant extracts, preferably aloe juice and polymers. biological, preferably hyaluronic acid or its salts and essential oils having a bactericidal and lenitive effect, preferably clove oil, lavender, cedar and vetiver. 7. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4, 5 et 6, caractérisé par le fait que ce mélange contient des sels anorganiques ou organiques comme l'oxyde ou l'orotate de zinc et des silicates avec action lénitive comme le verre bio active ( NovaMin 4505). 7. honey bee mixture for the dermatological treatment of chronic wounds according to claim 1, 2, 3, 4, 5 and 6, characterized in that this mixture contains inorganic or organic salts such as oxide or orotate zinc and silicates with lenitive action such as bioactive glass (NovaMin 4505). 8. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4, 5, 6 et 7, caractérisé par le fait que le miel utilisé provient principalement de la fleur de lavandula stoechas L. 8. Mix of honey bees for the dermatological treatment of chronic wounds according to claims 1, 2, 3, 4, 5, 6 and 7, characterized in that the honey used comes mainly from the lavandula stoechas L. flower. 9. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4, 5, 6, 7 et 8, caractérisé par le fait que le mélange est transformé dans une préparation galénique de forme agréable et facilement applicable à l'aide des gélifiants anorganiques et organiques et des huiles lipophiles ayant un effet soignant sur la peau. 9. Mix of honey bees for dermatological treatment of chronic wounds according to claim 1, 2, 3, 4, 5, 6, 7 and 8, characterized in that the mixture is converted into a galenic preparation of pleasant shape and easily applicable using inorganic and organic gelling agents and lipophilic oils having a caring effect on the skin. 10. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4, 5, 6, 7, 8 et 9, caractérisé par le fait que quelques-uns des produits actives mentionnées qui ne sont pas stables chimiquement à long terme dans le mélange sont stockées séparément dans un emballage à deux compartiments et sont mélangés avec l'autre partie immédiatement avant l'application. Honey bee mixture for the dermatological treatment of chronic wounds according to claim 1, 2, 3, 4, 5, 6, 7, 8 and 9, characterized in that some of the active products mentioned which are not not chemically stable long-term in the mixture are stored separately in a two-compartment package and are mixed with the other part immediately before application. 11. Mélange de miel d'abeilles pour le traitement dermatologique des plaies difficilement guérissables selon revendication 1, 2, 3,4, 5, 6, 7, 8, 9 et 10, caractérisé par le fait que la composition du mélange est adaptée au cours de la guérison: 11. Mix of honey bees for the dermatological treatment of wounds difficult to cure as claimed in claims 1, 2, 3,4, 5, 6, 7, 8, 9 and 10, characterized in that the composition of the mixture is adapted to course of healing: a) Au début en phase d'infection avec d'avantage des substances actives à action microbicide et anti-inflammatoire plus prononcée pour contrôler l'infection et L'inflammation et en suite a) At the beginning of the infection phase with more active substances with a more pronounced microbicidal and anti-inflammatory action to control the infection and inflammation and then b) Quand la plaie arrive en phase d'épithelisation elle est traitée avec des mélanges qui contiennent d'avantage des produits à action lénitive et génératrice de tissue fortifiée. b) When the wound arrives in the epithelization phase, it is treated with mixtures which contain, moreover, products with a lenitive action and generating fortified tissue. 12. Mélange de miel d'abeilles pour le traitement dermatologique des plaies chroniques selon revendication 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 et 11, caractérisé par le fait que le mélange est absorbé sur un tissu ou non-tissé médical ou une base poudreuse pour faciliter le traitement des plaies. 12. Honey bee mixture for the dermatological treatment of chronic wounds according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11, characterized in that the mixture is absorbed on a Medical fabric or non-woven or powder base to facilitate the treatment of wounds.
CH01114/08A 2008-07-17 2008-07-17 Mixtures of bee honey for the dermatological treatment of chronic wounds. CH699182B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH01114/08A CH699182B1 (en) 2008-07-17 2008-07-17 Mixtures of bee honey for the dermatological treatment of chronic wounds.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01114/08A CH699182B1 (en) 2008-07-17 2008-07-17 Mixtures of bee honey for the dermatological treatment of chronic wounds.

Publications (2)

Publication Number Publication Date
CH699182A1 true CH699182A1 (en) 2010-01-29
CH699182B1 CH699182B1 (en) 2012-03-15

Family

ID=41620975

Family Applications (1)

Application Number Title Priority Date Filing Date
CH01114/08A CH699182B1 (en) 2008-07-17 2008-07-17 Mixtures of bee honey for the dermatological treatment of chronic wounds.

Country Status (1)

Country Link
CH (1) CH699182B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012151438A1 (en) * 2011-05-05 2012-11-08 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
WO2014202851A1 (en) * 2013-06-20 2014-12-24 Melipharm Healing composition and use thereof
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
CN109152716A (en) * 2016-05-10 2019-01-04 高露洁-棕榄公司 Taurine and aloe collaboration anti-irritant composition and method
WO2019063997A1 (en) * 2017-09-27 2019-04-04 Brightwake Limited Compositions for wound treatment
US10272108B2 (en) 2011-05-05 2019-04-30 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785972A (en) * 1997-01-10 1998-07-28 Tyler; Kathleen A. Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application
WO2002000269A1 (en) * 2000-06-30 2002-01-03 Phillip Roy Caskey The use of honey in wound dressings
CA2455776A1 (en) * 2001-08-08 2003-02-20 Professional Dietetics S.R.L. Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
CH695414A5 (en) * 2001-05-30 2006-05-15 Guenter Holzner Cosmetic preparation, useful e.g. for treating aging of human skin, comprises anti-oxidizing, reducing, methylating or protein-diminishing active agents (comprising e.g. combination of hydrophilic and lipophilic molecules)
WO2008049578A2 (en) * 2006-10-27 2008-05-02 Cnci Bvba Method for sterilizing unheated raw honey. a honey-based wound care preparation. a wound care treatment product, and a biscuit based on honey
WO2008079898A1 (en) * 2006-12-20 2008-07-03 Pharmwest, Inc. Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5785972A (en) * 1997-01-10 1998-07-28 Tyler; Kathleen A. Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application
WO2002000269A1 (en) * 2000-06-30 2002-01-03 Phillip Roy Caskey The use of honey in wound dressings
CH695414A5 (en) * 2001-05-30 2006-05-15 Guenter Holzner Cosmetic preparation, useful e.g. for treating aging of human skin, comprises anti-oxidizing, reducing, methylating or protein-diminishing active agents (comprising e.g. combination of hydrophilic and lipophilic molecules)
CA2455776A1 (en) * 2001-08-08 2003-02-20 Professional Dietetics S.R.L. Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the ophthalmic field
WO2008049578A2 (en) * 2006-10-27 2008-05-02 Cnci Bvba Method for sterilizing unheated raw honey. a honey-based wound care preparation. a wound care treatment product, and a biscuit based on honey
WO2008079898A1 (en) * 2006-12-20 2008-07-03 Pharmwest, Inc. Methods and topical formulations comprising colloidal metal for treating or preventing skin conditions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Henriques A; Burton N F; Cooper R A, Antibacterial activity of selected Portuguese honeys, Journal of Apicultural Research 2005, Vol. 44, No. 3, Pg. 119-123, 01.11.2005, ISSN 0021-8839, [PREV200510253672] *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012151438A1 (en) * 2011-05-05 2012-11-08 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
US10272108B2 (en) 2011-05-05 2019-04-30 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
WO2014202851A1 (en) * 2013-06-20 2014-12-24 Melipharm Healing composition and use thereof
FR3007291A1 (en) * 2013-06-20 2014-12-26 Melipharm CICATRISANTE COMPOSITION AND USE
US20150150930A1 (en) * 2013-12-02 2015-06-04 Laïd BOUKRAA Aro-honey starch gel for wounds, burns and skin care
CN109152716A (en) * 2016-05-10 2019-01-04 高露洁-棕榄公司 Taurine and aloe collaboration anti-irritant composition and method
US10709907B2 (en) 2016-05-10 2020-07-14 Colgate-Palmolive Company Taurine and aloe synergistic anti-irritant compositions and methods
CN109152716B (en) * 2016-05-10 2021-07-02 高露洁-棕榄公司 Synergistic anti-irritant compositions and methods of taurine and aloe vera
US11160996B2 (en) 2016-05-10 2021-11-02 Colgate-Palmolive Company Taurine and aloe synergistic anti-irritant compositions and methods
WO2019063997A1 (en) * 2017-09-27 2019-04-04 Brightwake Limited Compositions for wound treatment

Also Published As

Publication number Publication date
CH699182B1 (en) 2012-03-15

Similar Documents

Publication Publication Date Title
US20230112199A1 (en) Marine extract compositions and methods of use
JP3917370B2 (en) Skin and tissue protection and / or therapeutic agents
CA2227977C (en) Use in a composition of an extract of at least one labiate
US11058735B2 (en) Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract
CH699182A1 (en) bee honey mixtures for dermatological treatment of chronic wounds.
US11564963B2 (en) Topical compositions, process of large-scale manufacture, and method of use
CN104825347B (en) A kind of medical bio whitening and spot-eliminating dressing and preparation method thereof
KR20190001166A (en) Cosmetic composition for regeneration of skin by using the extract of abeliophyllum distichum
KR20120107864A (en) Composition used for treating skin diseases, preparation comprising said composition and production method therefor
KR20220032352A (en) Shampoo for pets
CA3188531A1 (en) Topical compositions, process of large-scale manufacture, and method of use
EP1194136B1 (en) Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract
ES2289600T3 (en) AGENT AND METHOD TO INCREASE THE PENETRATION OF PRODUCTION FROM THE SEEDS OF CAÑAMO.
FR2837705A1 (en) Use of a mixture of essential oils in cosmetic antiwrinkle products and venous regeneration products
EP3506876B1 (en) Composition for nail fungus
CA2745579C (en) Thick pine needle extract composition for capsulation
WO2019080983A1 (en) Novel formulation based on chitosan and method for producing same
RU2680517C1 (en) Method of the intimate pant therapy and prophylactic cream production
RU2400214C1 (en) Healing and regenerative skin care product
ITLI20110005A1 (en) COMPOSITION FOR THE CARE OF PSORIASIS AND RELATED SKIN DISEASES
RU2157175C1 (en) Natural cream
RU2312671C2 (en) Biologically active supplement &#34;kavelain&#34; for cosmetic articles
RO135808A2 (en) Nourishing regenerating cream with total lipid extract of rapana (rapana venosa) and hemp oil
FR2773077A1 (en) Composition for treatment of wounds and ulcers contains glycerol, sucrose, sorbitol or mannitol
FR3015278A1 (en) OILY MACERATE OF PATIRON (CUCURBITA MAXIMA) FOR A COSMETIC USE

Legal Events

Date Code Title Description
PL Patent ceased